Toll-like receptor 7 and Toll-like receptor 9 agonists effectively enhance immunological memory in Plasmodium chabaudi infected BALB/c mice

被引：3
|
作者：
Gao, Wenyan [1 ,2 ]
Sun, Xiaodan [1 ]
Li, Danni [1 ]
Sun, Lin [1 ]
He, Yang [1 ]
Wei, Huanping [1 ]
Jin, Feng [3 ]
Cao, Yaming [1 ]
机构：
[1] China Med Univ, Dept Immunol, Basic Med Coll, Shenyang 110122, Liaoning, Peoples R China
[2] China Med Univ, Dept Obstet, Hosp 1, Shenyang 110001, Liaoning, Peoples R China
[3] China Med Univ, Dept Breast Surg, Hosp 1, Shenyang 110001, Liaoning, Peoples R China
来源：
INTERNATIONAL IMMUNOPHARMACOLOGY | 2020年 / 81卷
基金：
中国国家自然科学基金;
关键词：
PROTECTIVE IMMUNITY; CELL RESPONSES; B-CELLS; DIFFERENTIATION; FALCIPARUM; VACCINES; MALARIA; IMMUNOGENICITY; ADJUVANTS; ANTIBODY;
D O I：
10.1016/j.intimp.2020.106248
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页数：8
相关论文
共 50 条
  • [11] The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
    Huang, Lingling
    Ge, Xiaoyan
    Liu, Yang
    Li, Hui
    Zhang, Zhiyue
    PHARMACEUTICS, 2022, 14 (06)
  • [12] Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians
    Hamdy, Shaimaa
    Osman, Ahmed M.
    Zakaria, Zainab A.
    Galal, Iman
    Sobhy, Maha
    Hashem, Mohamed
    Allam, Walaa R.
    Abdel-Samiee, Mohamed
    Rewisha, Eman
    Waked, Imam
    Abdelwahab, Sayed F.
    ARCHIVES OF VIROLOGY, 2018, 163 (09) : 2433 - 2442
  • [13] Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine
    Wolska, Anna
    Cebula-Obrzut, Barbara
    Smolewski, Piotr
    Robak, Tadeusz
    LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1268 - 1278
  • [14] Toll-Like Receptor 9 Deficiency Breaks Tolerance to RNA-Associated Antigens and Up-Regulates Toll-Like Receptor 7 Protein in Sle1 Mice
    Celhar, Teja
    Yasuga, Hiroko
    Lee, Hui Yin
    Zharkova, Olga
    Tripathi, Shubhita
    Thornhill, Susannah I.
    Lu, Hao K.
    Au, Bijin
    Lim, Lina H. K.
    Thamboo, Thomas P.
    Akira, Shizuo
    Wakeland, Edward K.
    Connolly, John E.
    Fairhurst, Anna-Marie
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (10) : 1597 - 1609
  • [15] Synthetic Toll-like receptor agonists for the development of powerful malaria vaccines: a patent review
    Kaur, Arshpreet
    Kannan, Deepika
    Mehta, Surinder K.
    Singh, Shailja
    Salunke, Deepak B.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2018, 28 (11) : 837 - 847
  • [16] Modulating Toll-like Receptor 7 and 9 Responses as Therapy for Allergy and Autoimmunity
    Matesic, Damir
    Lenert, Aleksander
    Lenert, Petar
    CURRENT ALLERGY AND ASTHMA REPORTS, 2012, 12 (01) : 8 - 17
  • [17] Toll-like Receptor 9 Agonists as Adjuvants for Nanoparticle-Based Nicotine Vaccine
    Hu, Yun
    Smith, Daniel
    Frazier, Evan
    Zhao, Zongmin
    Zhang, Chenming
    MOLECULAR PHARMACEUTICS, 2021, 18 (03) : 1293 - 1304
  • [18] Modulating Toll-like Receptor 7 and 9 Responses as Therapy for Allergy and Autoimmunity
    Damir Matesic
    Aleksander Lenert
    Petar Lenert
    Current Allergy and Asthma Reports, 2012, 12 : 8 - 17
  • [19] N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2
    Willems, Marian M. J. H. P.
    Zom, Gijs G.
    Khan, Selina
    Meeuwenoord, Nico
    Melief, Cornelis J. M.
    van der Stelt, Mario
    Overkleeft, Herman S.
    Codee, Jeroen D. C.
    van der Marel, Gijsbert A.
    Ossendorp, Ferry
    Filippov, Dmitri V.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6873 - 6878
  • [20] Toll-like receptor 9 antagonizes antibody affinity maturation
    Akkaya, Munir
    Akkaya, Billur
    Kim, Ann S.
    Miozzo, Pietro
    Sohn, Haewon
    Pena, Mirna
    Roesler, Alexander S.
    Theall, Brandon P.
    Henke, Travis
    Kabat, Juraj
    Lu, Jinghua
    Dorward, David W.
    Dahlstrom, Eric
    Skinner, Jeff
    Millers, Louis H.
    Pierce, Susan K.
    NATURE IMMUNOLOGY, 2018, 19 (03) : 255 - +
12345